Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Coronary Artery Bypass Graft Procedures Market, Graft Type
7.1. Coronary Artery Bypass Graft Procedures Market, Graft Type, 2021-2028
7.1.1. Saphenous Vein Grafts
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Internal Thoracic Artery Grafts
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Other Grafts
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Coronary Artery Bypass Graft Procedures Market, Surgery Type
8.1. Coronary Artery Bypass Graft Procedures Market, Surgery Type, 2021-2028
8.1.1. Single CABG Surgery
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Double CABG Surgery
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Triple CABG Surgery
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Quadruple CABG Surgery
8.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Coronary Artery Bypass Graft Procedures Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.1.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.1.3.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.1.4.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.2. Europe
9.2.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.2.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.2.3.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.2.4.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.2.5.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.2.6.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.3. APAC
9.3.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.3.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.3.3.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.3.4.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.3.5.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.3.6.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.4. MEA
9.4.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.4.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.4.3.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.4.4.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.4.5.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.4.6.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.5. Latin America
9.5.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.5.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.5.3.2. Market Revenue and Forecast, Surgery Type (2016-2028)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, Graft Type (2016-2028)
9.5.4.2. Market Revenue and Forecast, Surgery Type (2016-2028)
Chapter 10. Company Profiles
10.1. Boston Scientific Corporation (NYSE: BSX)
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. KARL STORZ GmbH & Co. KG
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Boston Scientific
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. MAQUET Holding B.V. & Co.KG
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Ethicon US, LLC. (Johnson & Johnson)
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Genesee Biomedical, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms